NFE2L2 and Parkinson disease: Finally, several polymorphisms in the promotor region of NRF2 and the Nrf2 binding region of the microtubule-associated protein tau (MAPT) promoter, a known transcriptional activator of HMOX1, have been associated with PD [38,39].